large case series
Recently Published Documents


TOTAL DOCUMENTS

155
(FIVE YEARS 59)

H-INDEX

21
(FIVE YEARS 4)

Author(s):  
Stefanie Hübner ◽  
Agnes Schwieger‐Briel ◽  
Kristin Technau‐Hafsi ◽  
Sorina Danescu ◽  
Adrian Baican ◽  
...  

2021 ◽  
Vol 40 (9) ◽  
pp. 583-586
Author(s):  
Alessandro Albizzati ◽  
Cristina Riva Crugnola ◽  
Margherita Moioli ◽  
Elena Ierardi

Fasting before procedural sedation is a hot topic in everyday medical life with the main concern regarding pulmonary aspiration. Fasting guidelines before procedural sedation have always been the same as those used for general anaesthesia. However, procedural sedation and general anaesthesia differ in terms of invasiveness, drugs, duration and patient characteristics. This results in lower risk of pulmonary aspiration during procedural sedation, when compared to general anaesthesia. Moreover, a large case series of sedations performed in the emergency department with no respect for the proper fasting times showed no association between fasting duration and any type of adverse event with the latter occurring also in patients that properly fasted. The type of procedure (with the need of airway management) and characteristics of the patient seem to matter more. Furthermore, prolonged fasting is uncomfortable and has been associated with hypoglycaemia and dehydration. For this reason, fasting guidelines before procedural sedation should be adapted on the presence of risk factors, such as ASA score, need for airway management, comorbidities, type of procedure and drug used.


2021 ◽  
Vol 40 (9) ◽  
pp. 576-582
Author(s):  
Arturo Penco ◽  
Francesca Peri ◽  
Federico Poropat ◽  
Ester Conversano ◽  
Egidio Barbi ◽  
...  

Fasting before procedural sedation is a hot topic in everyday medical life with the main concern regarding pulmonary aspiration. Fasting guidelines before procedural sedation have always been the same as those used for general anaesthesia. However, procedural sedation and general anaesthesia differ in terms of invasiveness, drugs, duration and patient characteristics. This results in lower risk of pulmonary aspiration during procedural sedation, when compared to general anaesthesia. Moreover, a large case series of sedations performed in the emergency department with no respect for the proper fasting times showed no association between fasting duration and any type of adverse event with the latter occurring also in patients that properly fasted. The type of procedure (with the need of airway management) and characteristics of the patient seem to matter more. Furthermore, prolonged fasting is uncomfortable and has been associated with hypoglycaemia and dehydration. For this reason, fasting guidelines before procedural sedation should be adapted on the presence of risk factors, such as ASA score, need for airway management, comorbidities, type of procedure and drug used.


2021 ◽  
Vol 15 (10) ◽  
pp. e01539
Author(s):  
Muhammad Yousef ◽  
Diana Bharucha-Goebel ◽  
Dimah Saade ◽  
Gilberto Averion ◽  
Carsten G. Bönnemann ◽  
...  

Author(s):  
Yener Aydin ◽  
Ali Bilal Ulas ◽  
Ilker Ince ◽  
Ercan Korkut ◽  
Hayri Ogul ◽  
...  

Author(s):  
Akhilesh K. Sonakar ◽  
Uzma Shamim ◽  
M V Padma Srivastava ◽  
Mohd Faruq ◽  
Achal K. Srivastava

2021 ◽  
pp. 109352662110155
Author(s):  
Jonathan C Slack ◽  
Marie-Anne Bründler ◽  
Erik Nohr ◽  
John B McIntyre ◽  
Kyle C Kurek

Background Pediatric fibroblastic/myofibroblastic tumors (PFMTs) can be challenging to definitively classify. Large case series or diagnostic updates have not been recently published despite identification of molecular alterations that could improve diagnostic accuracy. Our review of the literature found that over two-thirds of the more than 30 types of PFMTs harbor recurrent molecular alterations. We performed an institutional review of PFMTs to highlight limitations of a predominantly morphological classification, and evaluated the utility of a next-generation sequencing assay to aid diagnosis. Methods PFMTs identified over a period of 12 years were reviewed, categorized per the new WHO classification, and tested using the Oncomine Childhood Cancer Research Assay. Results Eighty-seven specimens from 58 patients were reviewed; 50 were chosen for molecular analysis, 16 (32%) lacking definitive classification. We identified alterations, some novel, in 33% of assayed cases. Expected alterations were identified for most known diagnoses and mutations were identified in 6 of 16 tumors (38%) that were initially unclassified. Conclusion We confirmed a significant subset of PFMTs remain difficult to classify using current criteria, and that a combined DNA/RNA assay can identify alterations in many of these cases, improving diagnostic certainty and suggesting a clinical utility for challenging cases.


Author(s):  
Sharon C. Reale ◽  
Michaela K. Farber ◽  
Mario I. Lumbreras-Marquez ◽  
Jean M. Connors ◽  
Jean M. Carabuena

Sign in / Sign up

Export Citation Format

Share Document